Insurtech unicorn production line looks strong but are valuations rational?

Two insurtechs attained unicorn status in Q1 and there were more additions to this growing club this month, with observers suggesting there are plenty more insurtechs on the production line that will make the grade this year either through new funding rounds or SPAC combinations.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Andy Stone

Sales manager

+44 (0) 77 4160 9204

andy.stone@thomsonreuters.com

    Ricky Lamey

    Business development executive

    ricky.lamey@thomsonreuters.com